Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of Clinical Microbiology
|
January 1, 1987
Comparative sensitivity of 125I-protein A and enzyme-conjugated antibodies for detection of immunoblotted proteins
J M Bernstein, C E Stokes, B Fernie
Biochemistry
|
June 22, 1993
Structure of the human C6 gene
M J Hobart, B Fernie, R G DiScipio
Journal of Supramolecular Structure
|
January 1, 1979
The errors in assembly of MuLV in interferon treated cells
P M Pitha, B Fernie, F Maldarelli, et al.
The Journal of General Virology
|
January 1, 1980
Effect of interferon on mouse leukaemia virus (MuLV). V. Abnormal proteins in virions of Rauscher MuLV produced in the presence of interferon
P M Pitha, B Fernie, F Maldarelli, et al.
The Journal of Infectious Diseases
|
December 1, 1990
Frequency of indeterminate western blot tests in healthy adults at low risk for human immunodeficiency virus infection. The NIAID AIDS Vaccine Clinical Trails Network
K Midthun, L Garrison, M L Clements, et al.
Diagnostic Microbiology and Infectious Disease
|
June 1, 1984
Monoclonal antibodies for the rapid diagnosis of respiratory syncytial virus infection by immunofluorescence
C L Kao, K McIntosh, B Fernie, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 15, 1989
Viral antigen stimulation of the production of human monokines capable of regulating HIV1 expression
K A Clouse, P B Robbins, B Fernie, et al.
Developments in Biologicals
|
November 19, 2002
Detection and consequences of recombinant protein isoforms: implications for biological potency
M M Federici Jamrogowicz, K Venkat, N Bam, et al.
AIDS Research and Human Retroviruses
|
November 1, 1990
Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay. NIAID AIDS Vaccine Clinical Trials Network
R Viscidi, E Ellerbeck, L Garrison, et al.
Developments in Biologicals
|
November 19, 2003
Detection and consequences of recombinant protein isoforms: implications for biological potency
M M Federici, K Venkat, N Bam, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of Clinical Microbiology
|
January 1, 1987
Comparative sensitivity of 125I-protein A and enzyme-conjugated antibodies for detection of immunoblotted proteins
J M Bernstein, C E Stokes, B Fernie
Biochemistry
|
June 22, 1993
Structure of the human C6 gene
M J Hobart, B Fernie, R G DiScipio
Journal of Supramolecular Structure
|
January 1, 1979
The errors in assembly of MuLV in interferon treated cells
P M Pitha, B Fernie, F Maldarelli, et al.
The Journal of General Virology
|
January 1, 1980
Effect of interferon on mouse leukaemia virus (MuLV). V. Abnormal proteins in virions of Rauscher MuLV produced in the presence of interferon
P M Pitha, B Fernie, F Maldarelli, et al.
The Journal of Infectious Diseases
|
December 1, 1990
Frequency of indeterminate western blot tests in healthy adults at low risk for human immunodeficiency virus infection. The NIAID AIDS Vaccine Clinical Trails Network
K Midthun, L Garrison, M L Clements, et al.
Diagnostic Microbiology and Infectious Disease
|
June 1, 1984
Monoclonal antibodies for the rapid diagnosis of respiratory syncytial virus infection by immunofluorescence
C L Kao, K McIntosh, B Fernie, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 15, 1989
Viral antigen stimulation of the production of human monokines capable of regulating HIV1 expression
K A Clouse, P B Robbins, B Fernie, et al.
Developments in Biologicals
|
November 19, 2002
Detection and consequences of recombinant protein isoforms: implications for biological potency
M M Federici Jamrogowicz, K Venkat, N Bam, et al.
AIDS Research and Human Retroviruses
|
November 1, 1990
Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay. NIAID AIDS Vaccine Clinical Trials Network
R Viscidi, E Ellerbeck, L Garrison, et al.
Developments in Biologicals
|
November 19, 2003
Detection and consequences of recombinant protein isoforms: implications for biological potency
M M Federici, K Venkat, N Bam, et al.
Page
of 2